FDA authorizes another batch of J&J vaccine, saent does to Mexico, delays for Europe

FDA authorizes another batch of J&J vaccine The Food and Drug Administration (FDA) has authorized another batch of Johnson & Johnson's (J&J) coronavirus vaccine manufactured at a troubled Baltimore facility. Jordan Williams TheHill

The Food and Drug Administration (FDA) has authorized another batch of Johnson & Johnson's (J&J) coronavirus vaccine manufactured at a troubled Baltimore facility.

The agency said in a short statement on Tuesday that it authorized an additional batch from the Emergent BioSolutions facility, bringing the total number of authorized batches to three.

The agency did not specify how many doses were in the batch that it approved. 

However, a source familiar with the situation confirmed that roughly 14 million doses had been authorized. 

"We welcome the approval of an additional batch of J&J vaccine made at Emergent. We remain committed to addressing the FDA’s observations in order to resume production as soon as possible and look forward to continuing our work to end this pandemic," Emergent said in a statement. ...

The announcement comes after the FDA cleared two batches from the Emergent plant on Friday. The New York Times reported that 10 million doses will be allowed to be distributed, but another 60 million were deemed unusable....

ALSO SEE: EU says J&J to miss vaccine supply target in second quarter

ALSO: U.S. sent 1.35 million doses of J&J vaccine to Mexico overnight

https://www.nbcnews.com/politics/white-house/u-s-sending-1-35-million-doses-j-j-vaccine-n1270820